Finanças

Discussões Sinais técnicos Sazonais

Lucro líquido diluído disponível para acionistas ordinários de FREDUN PHARMACEUTICALS LIMITED.

Dados anuais

2016

2017

2018

2019

2020

2021

2022

2023

TTM

‪0,00‬

‪‪50,00 M‬‬

‪‪100,00 M‬‬

‪‪150,00 M‬‬

‪‪200,00 M‬‬

Período

Valor

Variação

Variação %

TTM

‪‪173,52 M‬‬

+‪‪17,28 M‬‬

+‪11,06‬%

2023

‪‪156,23 M‬‬

+‪‪48,17 M‬‬

+‪44,57‬%

2022

‪‪108,07 M‬‬

+‪‪44,71 M‬‬

+‪70,58‬%

2021

‪‪63,35 M‬‬

+‪‪43,21 M‬‬

+‪214,46‬%

2020

‪‪20,15 M‬‬

+‪‪1,13 M‬‬

+‪5,93‬%

2019

‪‪19,02 M‬‬

‪‪−25,58 M‬‬

‪−57,36‬%

2018

2017

2016

Dados trimestrais

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q3 '24

‪0,00‬

‪‪15,00 M‬‬

‪‪30,00 M‬‬

‪‪45,00 M‬‬

‪‪60,00 M‬‬

Período

Valor

Variação

Variação %

Q3 '24

‪‪53,33 M‬‬

+‪‪12,03 M‬‬

+‪29,12‬%

Q1 '24

‪‪41,30 M‬‬

‪‪−9,32 M‬‬

‪−18,42‬%

Q4 '23

‪‪50,62 M‬‬

+‪‪8,39 M‬‬

+‪19,87‬%

Q3 '23

‪‪42,23 M‬‬

+‪‪2,87 M‬‬

+‪7,29‬%

Q2 '23

‪‪39,36 M‬‬

+‪‪15,35 M‬‬

+‪63,89‬%

Q1 '23

‪‪24,02 M‬‬

‪‪−14,90 M‬‬

‪−38,28‬%

Q4 '22

‪‪38,91 M‬‬

+‪‪4,35 M‬‬

+‪12,58‬%

Q3 '22

‪‪34,57 M‬‬

+‪‪3,04 M‬‬

+‪9,64‬%

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20

Q4 '19

Q3 '19

Q2 '19

Q1 '19

Q4 '18

Q3 '18

Q2 '18

Q1 '18

Q4 '17